-
Ebola vaccine trial begins in DR Congo
-
Leclerc tops times for Ferrari in practice for US Grand Prix
-
Travelling man Wade equals Prem try record
-
Lula, Bolsonaro lock horns in final debate before Brazil vote
-
Rescuers search for seven people in Nairobi building collapse
-
Poulter and Hatton leave LIV Golf
-
Sacha Baron Cohen revives the 'problematic dinosaur' Ali G in new film
-
Blakely vaults out of the shadow of Biles for all-around world title
-
New race in Barcelona tops 17-event '27 IndyCar season
-
Oil tops $116 with stocks mixed on earnings, AI
-
Neymar backs Flavio Bolsonaro in Brazil election
-
Trump orders lawsuit to block Alaska Senate result if Republicans lose
-
Melania Trump says she brokered truce in war-torn Ukrainian city
-
Ebola patient in Nigeria is Swiss, had not visited DR Congo: Bern
-
Leclerc tops times for Ferrari in opening practice for US Grand Prix
-
Messi receives top Spanish award from heir to throne
-
Bayern Munich coach Kompany in hospital after collapsing
-
Macron condemns 'racist terrorist attack' after deadly shooting near Paris
-
Signs point to renewed major US military ops against Iran
-
Shiffrin sidesteps slalom in 'exploration' season
-
European, Mideast foreign ministers push peace and diplomacy at Istanbul talks
-
Bayern Munich coach Kompany in hospital after collapsing: club
-
Ex-All Black centre Williams undergoes 'miracle' heart surgery
-
Alonso sees Courtois similarities in Chelsea's Penders
-
Netanyahu launches major West Bank operation after Israeli soldiers killed
-
Melania Trump announces truce in Ukrainian city 'on brink of disaster'
-
AFP photographer captures striking images from West Bank attack
-
Saka to be carefully managed after latest injury setback, says Arteta
-
Oil hits $116 with stocks mixed on earnings, AI
-
Goodell says NFL's France debut 'just the beginning'
-
De Zerbi says Tottenham's dire record at Chelsea 'more motivation'
-
Singapore widens haze probe to local firms linked to Indonesian fires
-
Lula, Bolsonaro in final debate showdown before Brazil vote
-
Hundreds of Syrians protest repeated Israeli incursions
-
Poulter latest golfer to leave LIV
-
El Salvador sends troops to Haiti to find 4 missing soldiers
-
Gunman kills one, wounds five in town outside Paris
-
Liverpool must go 'full gas' despite injury issues, says Iraola
-
Melania Trump says secured ceasefire in Ukrainian city of Oleshky
-
Oil hits $115 with stocks mixed on earnings, AI
-
Carrick 'confident' he can turn around Man Utd slump
-
Casualties feared as multi-storey building collapses in Nairobi
-
PSG v Lyon French Ligue 1 game postponed due to Paris protests
-
Man Utd defeat to Como 'unacceptable', says Carrick
-
Meghan Markle 'distressed' over claims father had child abuse images
-
Hurzeler 'focused' on Brighton job despite Man Utd links
-
Gunman kills one, wounds four in town outside Paris
-
Hammer blow for Kenya as world marathon champ Jepchirchir suspended for doping
-
France to deploy 70,000 police ahead of new protests
-
Latin America's right-wing swing looms large over nature summit
BioLargo Presentation Deck at LD Micro Event Available Online
Cellinity battery cell technology, BioLargo's role in the global AI infrastructure investment cycle, and a general corporate update are featured in the presentation.
WESTMINSTER, CA, CA / ACCESS Newswire / October 21, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator that creates and commercializes sustainable technologies, today announced that its CEO presented at the LD Micro Main Event XIX, held at the Hotel del Coronado in San Diego, California, on Monday, October 20, at 2:00 p.m. Pacific Time.
In connection with the event, the company filed a Form 8-K on October 20, 2025, to provide a copy of the presentation materials, which are now available online and can be viewed at the following link: https://www.biolargo.com/sec-filings
About BioLargo, Inc.
BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Its core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy efficiency and safe on-site energy storage, and control infections and infectious disease. BioLargo's approach is to invent or acquire novel technologies, develop them into commercial offerings, and extend their reach through licensing and channel partnerships to maximize their impact. Visit www.BioLargo.com.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, those regarding BioLargo's ("the Company") expectations about anticipated revenue and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from those expressed or implied. More information on these risks and other potential factors is included in the Company's filings with the SEC, including its most recent Form 10-K, Form 10-Q, and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
SOURCE: BioLargo, Inc
View the original press release on ACCESS Newswire
P.Mathewson--AMWN